Cargando…
Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups
OBJECTIVE: The European Society of Gynaecological Oncology (ESGO)-quality indicators (QIs) for advanced ovarian cancer (AOC) have been assessed only by few Italian centers, and data are not available on the proportion of centers reaching the score considered for a satisfactory surgical management. T...
Autores principales: | Greggi, Stefano, Falcone, Francesca, Aletti, Giovanni D., Cascella, Marco, Bifulco, Francesca, Colombo, Nicoletta, Pignata, Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428297/ https://www.ncbi.nlm.nih.gov/pubmed/35712972 http://dx.doi.org/10.3802/jgo.2022.33.e60 |
Ejemplares similares
-
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022) -
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial
por: Capoluongo, E.D., et al.
Publicado: (2022) -
“Intestinal-Type” Vulvar Adenocarcinoma: A Review of the MITO Rare Tumors Group
por: Dellino, Miriam, et al.
Publicado: (2022) -
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study
por: Califano, Daniela, et al.
Publicado: (2021) -
Parallel NGO Networks for HIV Control: Risks and Opportunities for NGO Contracting
por: Zaidi, Shehla, et al.
Publicado: (2013)